MONTELUKAST

montelukast 5 mg chewable tablet, 28

MONTELUKAST (14553Y)

montelukast 5 mg chewable tablet, 28
14553Y
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  15643

Indication: Asthma
Treatment phase: First-line prevention

Restriction  15644

Indication: Asthma
Treatment phase: Prevention of condition
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 56 # of repeats: 5 DPMQ: $22.40 Max safety net: $23.88 General Patient Charge: $25.00
Available brands
APX-MONTELUKAST
MONTELAIR 5
MONTELUKAST-WGR
Montelukast Lupin
Montelukast Sandoz 5
Montelukast Viatris